Tango Therapeutics rebounds with a stronger pipeline, renewed focus on PRMT5 inhibitors, and key data ahead despite past ...

Vera Therapeutics stock rocketed nearly 70% on Monday on upbeat data for a kidney-disease trial. Shares are tumbling Friday ...

The HT2 trait in canola is designed to offer a more effective solution for controlling weeds resistant to commonly used herbicides. With the agricultural industry facing challenges from such resistant ...

Analysts at Truist Securities called the mid-stage data a "mixed bag," also flagging gastrointestinal adverse events. However ...

Vesting of each stock option is subject to such employee's continued service to Taysha on each vesting date. Taysha Gene Therapies (Nasdaq: TSHA) is a clinical-stage biotechnology company focused on ...

For decades, things went well for Bellevue Group. But now the sector weakness in biotechs could lead to losses.

Total gross proceeds of up to $150.0 million before the end of 2026 if all Series B warrants and Series C warrants are ...

Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to ...

Latest updates on Covid-19 in India and Southeast Asia, including vaccination status, variants, and expert advice on booster ...

Trump’s tariffs and the trade war continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

MAIA’s Chairman and CEO Vlad Vitoc, M.D., expressed optimism regarding the results, stating, "This new benchmark of 17.8 months median OS is nearly triple the recognized SOC data for third-line NSCLC ...

Any point can be considered low -- even after massive gains -- provided there is plenty of upside left. That brings us to ...